BB_emergence: Brainwave Entrainment During Emergence

Sponsor
Seoul National University Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05736510
Collaborator
(none)
106
1
2
12.3
8.6

Study Details

Study Description

Brief Summary

The investigators will compare whether there is a significant difference in the time required for general anesthesia recovery according to application of the binaural sound after surgery.

Condition or Disease Intervention/Treatment Phase
  • Other: Binaural sound
  • Other: Control
N/A

Detailed Description

After entering the operating room, electrocardiogram, pulse oxygen saturation, blood pressure meter, and sedline are attached to start monitoring vital signs and patient state index (PSI). propofol and the remifentanil continuous infusion device is connected as close as possible to the catheter insertion site. Anesthesia is induced with total intravenous anesthesia (4 ng/mL of Remifentanil, 4 mg/mL of propofol). Rocuronium is administered after checking the patient's unconsciousness. When appropriate neuromuscular blocking is reached, tracheal intubation is performed. The anesthesia maintenance is performed to keep stable vital sign and PSI between 25 and 50. End-tidal carbon dioxide is controlled to be between 30 mmHg and 40 mmHg.

When the pneumoperitoneum ends, the propofol concentration is recorded (T0). The anesthesiologist in charge of anesthesia puts headphones on the patient and plays the allocated file. The allocated file is named the screening number. Depending on the allocated group, the audio file is binaural sound for the experimental group, and a silent file for the control group.

The anesthesiologist cannot know group allocation, since the length and size of files are the same. Thereafter, the target of PSI is to be between 40 and 50. If the Psi increases above 50, increase the propofol concentration by 0.5 mg/mL and record it. Train of four counts keep between 1 to 3 (moderate block). When the operation is ended, stop anesthetics administration, and record the time (T1). At the same time, the investigators reverse neuromuscular blocking using sugammadex (2mg/ kg).

When the anesthesiologist starts waking the patient up, call the patient's name (unify into "OOO, open your eyes."). The anesthesiologist lightly tap the patient's shoulder and avoid excessive sound or stimulation.

Record the time (T2) when the PSI reaches 50, the time when the patient opens eyes (T3), and the time (T4) when the extubation of endotracheal tube was done. T3-T1 is the time it took the patient to open his eyes (primary end point). Write the effect site concentration of propofol and remifentanil recorded for each time points.

The patient's sedline EEG data from the end of pneumoperitoneum until the patient's exit operating room is collected as raw data. The patient's blood pressure and heart rate are measured at each time points. The investigators evaluate sedation and agitation of the patients using Ramsay Sedation Scale.

In the post-anesthesia care unit, pain score (NRS 0-10), postoperative nausea vomiting, medication, and length of stay are investigated.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
106 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Parallel Assignment A prospective randomized studyParallel Assignment A prospective randomized study
Masking:
Double (Investigator, Outcomes Assessor)
Primary Purpose:
Supportive Care
Official Title:
The Effect of Binaural Sound on Recovery of General Anesthesia in Patients Undergoing Laparoscopic Simple Gynecological Surgery
Anticipated Study Start Date :
Feb 15, 2023
Anticipated Primary Completion Date :
Nov 15, 2023
Anticipated Study Completion Date :
Feb 23, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Binaural

Exposed to binaural sound (40 Hz) from the end of pneumoperitoneum until the eyes are open

Other: Binaural sound
When the pneumoperitoneum ends, the anesthesiologist puts headphones on the patient and plays the allocated file. In the experimental group, the allocated file is binaural sound with 40Hz beat. Thereafter, the target of PSI is to be between 40 and 50. If the Psi increases above 50, increase the propofol concentration by 0.5 mg/mL and record it. Train of four counts keep between 1 to 3 (moderate block). When the operation is ended, stop anesthetics administration, and, we reverse neuromuscular blocking using sugammadex (2mg/ kg). When the anesthesiologist starts waking the patient up, call the patient's name (unify into "OOO, open your eyes."). The anesthesiologist lightly tap the patient's shoulder and avoid excessive sound or stimulation.

Active Comparator: Control

Applied silent files from the end of pneumoperitoneum until the eyes are open

Other: Control
When the pneumoperitoneum ends, the anesthesiologist puts headphones on the patient and plays the allocated file. In the control group, the allocated file is silent. Thereafter, the target of PSI is to be between 40 and 50. If the Psi increases above 50, increase the propofol concentration by 0.5 mg/mL and record it. Train of four counts keep between 1 to 3 (moderate block). When the operation is ended, stop anesthetics administration, and, we reverse neuromuscular blocking using sugammadex (2mg/ kg). When the anesthesiologist starts waking the patient up, call the patient's name (unify into "OOO, open your eyes."). The anesthesiologist lightly tap the patient's shoulder and avoid excessive sound or stimulation.

Outcome Measures

Primary Outcome Measures

  1. Eye opening time [after the anesthetic infusion is terminated until 1 hour]

    The time it takes to open patient's eyes in response to the voice after the anesthetic infusion is terminated.

Secondary Outcome Measures

  1. Extubation time [after the anesthetic infusion is terminated until 1 hour]

    The time it takes from the end of the anesthetic infusion to the extubation of endotracheal tube

  2. Systolic blood pressure [from the end of the anesthetic infusion to the exit of operating room until 1 hour]

    Noninvasive systolic blood pressure

  3. Diastolic blood pressure [from the end of the anesthetic infusion to the exit of operating room until 1 hour]

    Noninvasive diastolic blood pressure

  4. Mean blood pressure [from the end of the anesthetic infusion to the exit of operating room until 1 hour]

    Noninvasive mean blood pressure

  5. Heart rate [from the end of the anesthetic infusion to the exit of operating room until 1 hour]

    Heart rate

  6. alpha band activity [from the end of the anesthetic infusion to the exit of operating room until 1 hour]

    alpha band activity of electroencephalogram from Sedline data

  7. beta band activity [from the end of the anesthetic infusion to the exit of operating room until 1 hour]

    beta band activity of electroencephalogram from Sedline data

  8. theta band activity [from the end of the anesthetic infusion to the exit of operating room until 1 hour]

    theta band activity of electroencephalogram from Sedline data

  9. delta band activity [from the end of the anesthetic infusion to the exit of operating room until 1 hour]

    delta band activity of electroencephalogram from Sedline data

  10. Ramsay Sedation Scale [When the end of anesthesia within 5minutes]

    The degree of patient's sedation or agitation (1 to 6: 1 means "Patient is anxious and agitated or restless, or both"; 6 means "Patient exhibits no response")

  11. Postoperative recovery score [When the patient stay in post-anesthesia care unit up to 1 hour]

    Postoperative recovery score (0-10; activity (0-2), respiration (0-2), circulation (0-2), consciousness level (0-2), and color (0-2); optimum score 10)

  12. Pain score [When the patient stay in post-anesthesia care unit up to 1 hour]

    Postoperative pain score using numeric rating scale(0-10: 0, no pain; 10, worst possible pain)

  13. Rate of postoperative nausea and vomiting [When the patient stay in post-anesthesia care unit up to 1 hour]

    Rate of postoperative nausea and vomiting

  14. Length of stay in post-anesthesia care unit [From entering to exit the post-anesthesia care unit up to 2 hours]

    Length of stay in post-anesthesia care unit

  15. Medication [When the patient stay in post-anesthesia care unit up to 1 hour]

    Rate of administration of any medication in post-anesthesia care unit

Eligibility Criteria

Criteria

Ages Eligible for Study:
19 Years to 50 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients between 19 and 50 years of age who are scheduled to undergo laparoscopic salpingo-oophorectomy/ ovarian cystectomy

  • Intellectual level to understand the procedures of the clinical trial

  • Physical status classification of the American Society of Anesthesiology (ASA) 1-2 grades

Exclusion Criteria:
  • Patients with hearing loss or using hearing aids

  • Patients who have been given narcotic painkillers or sedative drugs within a week.

  • Alcohol-dependent or drug-dependent patients

  • Patients with drug hypersensitivity to anesthetics

  • Patients with arrhythmia, cardiovascular disease, impaired heart function, decreased circulatory blood flow

  • Patients with liver failure

  • Patients with other major medical or psychological disorder that will affect the treatment response

  • Patients with claustrophobia or anxiety disorder

  • Patients with organic brain disorders or other conditions that cannot be properly measured by PSI

  • Patients who have been newly diagnosed with myocardial infarction, cerebral ischemic seizure, stroke, clinically significant coronary artery disease, or have undergone percutaneous carotid coronary dilatation or coronary bypass treatment within 6 months

  • Patients with a history of epilepsy or seizures

  • Patients with acute angle glaucoma

  • Patients who deemed unsuitable for this clinical trial

Contacts and Locations

Locations

Site City State Country Postal Code
1 Seoul National University Hospital Seoul Korea, Republic of

Sponsors and Collaborators

  • Seoul National University Hospital

Investigators

  • Principal Investigator: Jeong-Hwa Seo, MD.,PhD., Seoul National University Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Jeong-Hwa Seo, Professor, Seoul National University Hospital
ClinicalTrials.gov Identifier:
NCT05736510
Other Study ID Numbers:
  • 2212-028-1383
First Posted:
Feb 21, 2023
Last Update Posted:
Feb 21, 2023
Last Verified:
Feb 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Jeong-Hwa Seo, Professor, Seoul National University Hospital

Study Results

No Results Posted as of Feb 21, 2023